TP53 and breast carcinoma: In the GDC TCGA breast cancer datasets, the SMDIC method identified 19 and 15 TP53 mutation-specific immune cell response in the xCell and ssGSEA cell abundance estimated methods (Table 2 and Supplementary Table 1).